U.S. Bancorp:企業の戦略・SWOT・財務情報

◆英語タイトル:U.S. Bancorp - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3952
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

U.S. Bancorp – Strategy, SWOT and Corporate Finance Report
Summary

U.S. Bancorp – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

U.S. Bancorp is a financial and banking holding company that offers retail and commercial banking, private banking, and wealth management solutions through its subsidiaries. The company offers savings and checking deposits, certificate of deposits, consumer and business loans, personal and business lines of credit, mortgages, insurance, savings and investment products, brokerage and fund services, credit and debit cards, asset and wealth management, and financial planning solutions. U.S. Bancorp also provides leasing, international banking, payment services, private banking, cash management, and online and mobile banking. The company primarily operates primarily in Midwest and West regions of the US. U.S. Bancorp is headquartered in Minneapolis, Minnesota, the US.

Scope

- Detailed information on U.S. Bancorp required for business and competitor intelligence needs
- A study of the major internal and external factors affecting U.S. Bancorp in the form of a SWOT analysis
- An in-depth view of the business model of U.S. Bancorp including a breakdown and examination of key business segments
- Intelligence on U.S. Bancorp’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about U.S. Bancorp, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of U.S. Bancorp and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess U.S. Bancorp as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on U.S. Bancorp’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
U.S. Bancorp: Company Overview 9
U.S. Bancorp: Overview and Key Facts 9
U.S. Bancorp: Overview 9
U.S. Bancorp: Key Facts 9
U.S. Bancorp: Key Employees 11
U.S. Bancorp: Key Employee Biographies 13
U.S. Bancorp: Major Products and Services 15
U.S. Bancorp: Company History 17
U.S. Bancorp: Management Statement 23
U.S. Bancorp: Locations and Subsidiaries 26
U.S. Bancorp: Key Competitors 29
U.S. Bancorp: Company Analysis 30
U.S. Bancorp: Business Description 30
U.S. Bancorp: SWOT Analysis 31
U.S. Bancorp: SWOT Overview 31
U.S. Bancorp: Strengths 31
U.S. Bancorp: Weaknesses 32
U.S. Bancorp: Opportunities 32
U.S. Bancorp: Threats 34
U.S. Bancorp: Corporate Financial Deals Activity 35
U.S. Bancorp: Financial Deals Overview 35
U.S. Bancorp: Targets and Partners 37
U.S. Bancorp: Top Deals 2014 – 2018YTD* 38
U.S. Bancorp: Advisors 39
U.S. Bancorp: Top Financial Advisors 39
U.S. Bancorp: Corporate Venturing 40
U.S. Bancorp: Capital Raising 41
U.S. Bancorp: Divestments 42
U.S. Bancorp: Recent Developments 43
U.S. Bancorp: News and Events Summary 43
U.S. Bancorp: Contracts 46
U.S. Bancorp: Corporate Governance 47
U.S. Bancorp: Financial Deals 48
U.S. Bancorp: Financial Performance 48
U.S. Bancorp: Regulatory and Legal Events 49
U.S. Bancorp: Strategy and Operations 49
Appendix 51
Contact Us 51
Methodology 51
About MarketLine 52

List of Tables
Table 1: U.S. Bancorp: Key Facts
Table 2: U.S. Bancorp: Key Employees
Table 3: U.S. Bancorp: Locations and Subsidiaries
Table 4: U.S. Bancorp: Key Competitors
Table 5: U.S. Bancorp: Deal Activity by Deal Type - Volume (TTM*)
Table 6: U.S. Bancorp: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: U.S. Bancorp: Targets and Partners
Table 8: U.S. Bancorp: Top Deals 2014 - 2018YTD*
Table 9: U.S. Bancorp: Financial Advisor Ranking by Value (US$m)
Table 10: U.S. Bancorp: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 11: U.S. Bancorp: Corporate Venturing by Geography (2014 - YTD*2018)
Table 12: U.S. Bancorp: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 13: U.S. Bancorp: Capital Raising by Deal Type (2014 - YTD*2018)
Table 14: U.S. Bancorp: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 15: U.S. Bancorp: Divestments by Geography (2014 - YTD*2018)
Table 16: U.S. Bancorp: News and Events Summary
Table 17: U.S. Bancorp: Contracts
Table 18: U.S. Bancorp: Corporate Governance
Table 19: U.S. Bancorp: Financial Deals
Table 20: U.S. Bancorp: Financial Performance
Table 21: U.S. Bancorp: Regulatory and Legal Events
Table 22: U.S. Bancorp: Strategy and Operations

List of Figures
Figure 1: U.S. Bancorp: Deal Activity by Deal Type - Volume (TTM*) 35
Figure 2: U.S. Bancorp: Deal Activity by Deal Type - Volume (2014 - YTD*2018) 36
Figure 3: U.S. Bancorp: Corporate Venturing Volume and Value Trend (2014 - YTD*2018) 40
Figure 4: U.S. Bancorp: Corporate Venturing by Geography (2014 - YTD*2018) 40
Figure 5: U.S. Bancorp: Capital Raising Volume and Value Trend (2014 - YTD*2018) 41
Figure 6: U.S. Bancorp: Capital Raising by Deal Type (2014 - YTD*2018) 41
Figure 7: U.S. Bancorp: Divestments Volume and Value Trend (2014 - YTD*2018) 42
Figure 8: U.S. Bancorp: Divestments by Geography (2014 - YTD*2018) 42

★海外企業調査レポート[U.S. Bancorp:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KENKO Mayonnaise Co Ltd:企業の戦略・SWOT・財務分析
    KENKO Mayonnaise Co Ltd - Strategy, SWOT and Corporate Finance Report Summary KENKO Mayonnaise Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Jefferies Group LLC:企業の戦略・SWOT・財務分析
    Jefferies Group LLC - Strategy, SWOT and Corporate Finance Report Summary Jefferies Group LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Rockcastle Global Real Estate Co Ltd:企業の戦略・SWOT・財務情報
    Rockcastle Global Real Estate Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Rockcastle Global Real Estate Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Ego Pharmaceuticals Pty Ltd:企業の戦略的SWOT分析
    Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Mari Petroleum Co Ltd (MARI):企業の財務・戦略的SWOT分析
    Mari Petroleum Co Ltd (MARI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Thomas Cook (India) Limited:企業の戦略・SWOT・財務情報
    Thomas Cook (India) Limited - Strategy, SWOT and Corporate Finance Report Summary Thomas Cook (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cogent Communications Holdings inc (CCOI):企業の財務・戦略的SWOT分析
    Cogent Communications Holdings inc (CCOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • OMV New Zealand Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary OMV New Zealand Ltd (OMV NZ) a subsidiary of OMV AG, is an oil and natural gas exploration and production company. It offers upstream production services with offshore oil and gas fields in Maari, Pohokura, and Maui across Taranaki coast, Tunisia and in the Black Sea. The company operates ex …
  • Alethia Biotherapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Alethia Biotherapeutics Inc (Alethia Biotherapeutics) is a biotechnology company that discovers and develops therapeutic products. The company’s products comprise AB-25E9 bone antiresorptive, AB-3A4 invasive carcinomas treatment products, and AB-16B5 EMT inhibitors. It also offers therapeuti …
  • Reliance Life Sciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Reliance Life Sciences Pvt Ltd (Reliance Life Sciences) a subsidiary of Reliance Industries Limited, is a biotechnology company which manufactures and develops medical products for healthcare industry. The company’s product portfolio includes plasma proteins, biosimilars, proteins, steroid, …
  • Osprey Medical Inc (OSP):企業の財務・戦略的SWOT分析
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company offers contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk p …
  • Teva Pharmaceutical Industries Limited:企業の戦略・SWOT・財務情報
    Teva Pharmaceutical Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Teva Pharmaceutical Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Continental Grain Company:企業の戦略・SWOT・財務分析
    Continental Grain Company - Strategy, SWOT and Corporate Finance Report Summary Continental Grain Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Barra Resources Limited:企業の戦略・SWOT・財務分析
    Barra Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Barra Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Dixons Carphone plc:企業のM&A・事業提携・投資動向
    Dixons Carphone plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dixons Carphone plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Hangzhou Tigermed Consulting Co Ltd (300347):企業の財務・戦略的SWOT分析
    Summary Hangzhou Tigermed Consulting Co Ltd (Tigermed) is a contract research organization (CRO) that provides clinical trial services. It offers regulatory submission and approval, medical translation and GMP (Good Manufacturing Practice) consulting, medical monitoring, project management, medical …
  • Kosmos Energy Ltd (KOS):企業の財務・戦略的SWOT分析
    Kosmos Energy Ltd (KOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • PolyNovo Biomaterials Pty Ltd:企業の製品パイプライン分析2018
    Summary PolyNovo Biomaterials Pty Ltd (PolyNovo), a subsidiary of PolyNovo Ltd is a medical technology company that develops, designs and manufactures controlled bioeroding tissue and orthopedic solutions. The company’s Novosorb polymers are based on polyurethanes, a polymer family used in medical a …
  • Avitide Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avitide Inc (Avitide) strives to discover, manufacture and commercialize molecule-specific affinity purification solutions for biopharmaceutical industry. It offers affinity purification resins for developing bio-molecules including enzymes, non-antibody therapeutics, bispecific antibodies, …
  • Golden Meditech Holdings Ltd (801):製薬・医療:M&Aディール及び事業提携情報
    Summary Golden Meditech Holdings Ltd (Golden Meditech) is a medical equipment provider that provides blood stem cells storage and hospital management solutions. The company provides autologous blood recovery systems. It offers hospital management, medical insurance administration and blood bank serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆